Brief: Irlab To Initiate Study Of IRL757 In Parkinsons's Disease

IRLAB Therapeutics AB

27/03/2025 06:25

March 27 (Reuters) - IRLAB Therapeutics AB IRLABa.ST:

IRLAB TO INITIATE STUDY OF IRL757 IN PARKINSONS'S DISEASE

FULL FINANCIAL BACKING FROM ITS DEVELOPMENT PARTNER MSRD

MSRD TO COVER STUDY STARTUP COSTS WITH $4.5 MILLION INITIAL PAYMENT

Source text: ID:nMFN6RdKjz

Further company coverage: [IRLABa.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))